Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026)
Annexon's (ANNX) quarterly Depreciation & Amortization (CF) came in at $539000.0 in Q1 2026, little changed year-on-year from $537000.0 in Q1 2025, and down 0.74% quarter-over-quarter from $543000.0 in Q4 2025.
Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Annexon's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $539000.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed 0.37% year-over-year to $539000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 0.88% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 0.74% from the prior year.
- Depreciation & Amortization (CF) fell to $539000.0 in Q1 2026 per ANNX's latest filing, from $543000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $546000.0 in Q3 2025 and bottomed at $518000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $538000.0 (2023), against an average of $535823.5.
- Biggest YoY gain for Depreciation & Amortization (CF) was 4.74% in 2022; the steepest drop was 7.33% in 2022.
- Year by year, Depreciation & Amortization (CF) stood at $530000.0 in 2022, then rose by 1.51% to $538000.0 in 2023, then fell by 0.19% to $537000.0 in 2024, then climbed by 1.12% to $543000.0 in 2025, then dropped by 0.74% to $539000.0 in 2026.
- Per Business Quant, the three latest ANNX Depreciation & Amortization (CF) figures stand at $539000.0 (Q1 2026), $543000.0 (Q4 2025), and $546000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 539,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 539,000.00 |
| Mar 31, 2026 | 539,000.00 |
| Dec 31, 2025 | 543,000.00 |
| Dec 31, 2025 | 543,000.00 |
| Sep 30, 2025 | 546,000.00 |
| Sep 30, 2025 | 546,000.00 |
| Jun 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 540,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Dec 31, 2024 | 537,000.00 |
| Dec 31, 2024 | 537,000.00 |
| Sep 30, 2024 | 538,000.00 |
| Sep 30, 2024 | 538,000.00 |
| Jun 30, 2024 | 537,000.00 |
| Jun 30, 2024 | 537,000.00 |
| Mar 31, 2024 | 538,000.00 |
| Mar 31, 2024 | 538,000.00 |
| Dec 31, 2023 | 538,000.00 |
| Dec 31, 2023 | 538,000.00 |